Filing Details
- Accession Number:
- 0001209191-17-059523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-06 20:43:48
- Reporting Period:
- 2017-11-02
- Accepted Time:
- 2017-11-06 20:43:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042074 | Cymabay Therapeutics Inc. | CBAY | Pharmaceutical Preparations (2834) | 943103561 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588862 | Charles Mcwherter | C/O Cymabay Therapeutics, Inc. 7999 Gateway Boulevard, Suite 130 Newark CA 94560 | Svp & Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-02 | 300 | $8.67 | 10,300 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-02 | 4,700 | $8.67 | 15,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
